|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net income (loss) | |||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||
| Amortization and depreciation | |||
| Sale of patent | |||
| Amortization of LOC commitment fees | |||
| Impairment loss | |||
| (Gain)/loss on disposal and fair value changes in investments | |||
| Stock-based compensation | |||
| Other Income | |||
| Decrease (increase) in assets: | |||
| Accounts receivable | |||
| Prepaid expenses | |||
| Increase (decrease) in liabilities: | |||
| Accounts payable | |||
| Accrued interest | |||
| Short-term advance to affiliate | |||
| Deferred revenues | |||
| Short-term advance from affiliate | |||
| Net cash flow (used in)/ provided by operating activities | |||
| Cash flows from investing activities: | |||
| Product development expenditures | |||
| Purchase of franchise and development rights | |||
| Purchase of real estate | |||
| Net cash flow (used in)/ provided by investing activities | |||
| Cash flows from financing activities: | |||
| Change in line of credit | |||
| Proceeds of short-term debt | |||
| Repayment of long-term debt | |||
| Net cash flow (used in)/provided by financing activities | |||
| Net increase (decrease) in cash | |||
| Cash – beginning of the year | |||
| Cash – end of the period | |||
| Supplemental cash flow information | |||
| Cash paid for interest | |||
| Cash paid for taxes | |||
| Sale of drone patent for common stock | |||
| Cash paid for interest | |||
| Cash divested in sale of Ecker Capital, Inc. |
Loading...
